https://longevity.stanford.edu/wp-content/uploads/2017/05/new-logo2-01-300x107.png 0 0 admin https://longevity.stanford.edu/wp-content/uploads/2017/05/new-logo2-01-300x107.png admin2011-06-20 20:54:132011-06-20 20:54:131/20/11 - F.D.A. Sees Promise in Alzheimer’s Imaging Drug
1/20/11 – F.D.A. Sees Promise in Alzheimer’s Imaging Drug
An advisory committee to the Food and Drug Administration recommended unanimously Thursday that the agency approve the first test — a brain scan — that can show the characteristic plaques of Alzheimer’s disease in the brain of a living person.